TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
China Bozza Development Holdings Limited ( (HK:1069) ) has issued an update.
China Health Technology Group Holding Company Limited announced the resignation of Mr. Wang Yibin from his roles as Executive Director and Chief Executive Officer, effective December 1, 2025, due to other business commitments. The company has appointed Ms. Bu Xue as the new Chief Executive Officer, highlighting her extensive experience in marketing and business development, and her qualifications in accounting and tax advisory. This leadership change is expected to bring fresh perspectives to the company, potentially impacting its strategic direction and operations.
The most recent analyst rating on (HK:1069) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Bozza Development Holdings Limited stock, see the HK:1069 Stock Forecast page.
More about China Bozza Development Holdings Limited
Average Trading Volume: 812,539
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$46.32M
See more data about 1069 stock on TipRanks’ Stock Analysis page.